Novel Macrolactams from a Deep-Sea-Derived <i>Streptomyces</i> Species

Pei Wang,Dongyang Wang,Rongxin Zhang,Yi Wang,Fandong Kong,Peng Fu,Weiming Zhu
DOI: https://doi.org/10.3390/md19010013
2021-01-01
Marine Drugs
Abstract:Four polyene macrolactams including the previously reported niizalactam C (4), and three new ones, streptolactams A-C (1-3) with a 26-membered monocyclic, [4,6,20]-fused tricyclic and 11,23-oxygen bridged [14,16]-bicyclic skeletons, respectively, were isolated from the fermentation broth of the deep-sea sediment-derived Streptomyces sp. OUCMDZ-3159. Their structures were determined based on spectroscopic analysis, X-ray diffraction analysis, and chemical methods. The abiotic formation of compounds 2 and 4 from compound 1 were confirmed by a series of chemical reactions under heat and light conditions. Compounds 1 and 3 showed a selective antifungal activity against Candida albicans ATCC 10231.
What problem does this paper attempt to address?